Trade Summary

3 days ago, Szot Matthew K, serving as CFO at Cadrenal Therapeutics, Inc. (CVKD), sold 9,933 shares at $6.97 per share, for a total transaction value of $69,233.00.

This sale represents a 100.00% decrease in Szot Matthew K's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 29, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, December 31, 2025, 2 days after the trade was made.

Cadrenal Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.